Guardant Health set to present 38 abstracts at ASCO annual meeting

Guardant Health

Guardant Health

GH

0.00
  • Guardant Health will attend the ASCO Annual Meeting in Chicago, May 29 to June 2, 2026.
  • The company plans to present 38 abstracts, including one oral presentation with Pfizer, highlighting liquid biopsy advances powered by InfinityAI.
  • Data include analytical validation supporting Guardant360 Liquid CDx as a pan-cancer companion diagnostic following recent FDA approval.
  • Additional presentations cover improved ALK fusion detection in NSCLC, methylation-based tumor classification, tissue-free MRD monitoring, recurrence tracking.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.